Company: MDCXW
Filing Date: 2025-03-07
Form Type: 253G1
Source: 0001062993-25-004966
Chunk: 212

Company: Medicus Pharma Ltd.
Filing Date: 2025-03-07
Form: 253G1
Chunk 212
---
 |
| Weighted average number of common shares outstanding during the period |   |  9,514,738 |   |   |            2,019,505 |   |   |  9,037,153 |   |   |           1,930,261 |   |
| Basic and diluted net loss per share attributable to shareholders      | $ |      (0.31 | ) | $ |                (1.47 | ) | $ |      (0.98 | ) | $ |               (2.04 | ) |

For all the periods presented, diluted loss per share equals basic loss per share due to the anti-dilutive effect of the note payable, convertible promissory notes, preferred shares and share options. The outstanding number and type of securities that could potentially dilute basic net loss per share in the future but would have decreased the loss per share (anti-dilutive) presented for the periods ended September 30, 2024 and 2023 are as follows:

|                       | September 30, 2024 | September 30, 2023 |
|:----------------------|-------------------:|:-------------------|
|                       |                  # | #                  |
| Share options         |            887,500 | -                  |
| Total dilutive shares |            887,500 | -                  |

8. General and administrative expenses

General and administrative expenses for the three and nine months ended September 30, 2024 and 2023 are comprised of:

|                                                           |     |      2024 |     | For the three months 
  ended September 30, 
                 2023 |     |      2024 |     | For the nine months 
 ended September 30, 
                2023 |
|:----------------------------------------------------------|:----|----------:|:----|---------------------:|:----|----------:|:----|--------------------:|
|                                                           |     |         $ |     |                    $ |     |         $ |     |                   $ |
| Professional fees                                         |     | 1,137,176 |     |              124,904 |     | 2,811,358 |     |             483,679 |
| Consulting fees                                           |     |   417,405 |     |               60,000 |     | 1,356,599 |     |             180,000 |
| Salaries, wages and benefits                              |     |   279,358